SEC Filing Document

Company: Jones Ventures INTL Acquisition1 Corp
Ticker: 
CIK: 2129056
Filing Type: DRS
Document Type: DRS
Date Filed: 2026-04-13
Accession Number: 0001213900-26-042636
Exchange: 
SIC Code: 6770
SIC Description: Blank Checks
URL: https://www.sec.gov/Archives/edgar/data/2129056/000121390026042636/filename1.htm

Chunk 137 of 140
Word Count: 1487
Character Count: 9763

Document Content:

and is therefore unenforceable. Pursuant to the Underwriting Agreement to be filed as Exhibit 1.1 to this Registration Statement, we will agree to indemnify the underwriters and the underwriters will agree to indemnify us against certain civil liabilities that may be incurred in connection with this offering, including certain liabilities under the Securities Act. Item 15. Recent Sales of Unregistered Securities. On June 18, 2021, the Sponsor purchased 5,750,000 Class B ordinary shares of the Company, par value $0.0001 (“Class B ordinary shares” and such shares purchased by the Sponsor, the “Founder Shares”), for a purchase price of $25,000. On March 13, 2026, the Company effected share capitalization and issued an additional 1,916,667 Class B ordinary shares to the Sponsor resulting in an aggregate of 7,666,667 Class B ordinary shares outstanding and held by the Sponsor. As a result, our Sponsor paid approximately $0.003 per founder share. Table of Contents

Such securities were issued in connection with our organization pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act. The number of founder shares outstanding was determined based on the expectation that the total size of this offering would be a maximum of 23,000,000 units if the underwriters’ over-allotment option is exercised in full and therefore that such founder shares would represent 25% of the outstanding ordinary shares after this offering (not including the Class A ordinary shares comprising part of the private placement units). Up to 1,000,000 of these shares will be surrendered for no consideration depending on the extent to which the underwriters’ over-allotment is exercised.

Our Sponsor is an accredited investor for purposes of Rule 501 of Regulation D. Each of the equity holders in our Sponsor is an accredited investor under Rule 501 of Regulation D. The sole business of our Sponsor is to act as the company’s Sponsor in connection with this offering.

Our Sponsor, and Jones, the representative of the underwriters, have committed, pursuant to written agreements, to purchase from us an aggregate of 645,000 private placement units (whether or not the underwriters’ over-allotment option is exercised) at $10.00 per unit (for an aggregate purchase price of $6,450,000 (whether or not the underwriters’ over-allotment option is exercised) in a private placement that will close simultaneously with the closing of this offering. Of those 645,000 private placement units (whether or not the underwriters’ over-allotment option is exercised), our Sponsor has agreed to purchase 245,000 private placement units (whether or not the underwriters’ over-allotment option is exercised) and underwriters have agreed to purchase 400,000 private placement units (whether or not the underwriters’ over-allotment option is exercised). These purchases will take place on a private placement basis simultaneously with the completion of our initial public offering. This issuance will be made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.

No underwriting discounts or commissions were paid with respect to such sales.

Item 16. Exhibits and Financial Statement Schedules.

(a)     Exhibits.    The following exhibits are filed as part of this registration statement:

Exhibit Description

1.1 Form of Underwriting Agreement**

1.2 Form of Business Combination Marketing Agreement**

3.1 Memorandum and Articles of Association**

3.2 Amended and Restated Memorandum and Articles of Association to be in effect at the closing of the Initial Public Offering**

4.1 Specimen Unit Certificate**

4.2 Specimen Right Certificate**

4.3 Form of Rights Agreement between Continental Stock Transfer & Trust Company and the Registrant**

5.1 Opinion of Maples and Calder (Cayman) LLP**

5.2 Opinion of King & Spalding LLP**

10.1 Securities Purchase Agreement, dated June 17, 2021, by and between the Registrant and Jones Ventures INTL Acquisition1 Sponsor LLC**

10.2 Promissory Note, dated June 17, 2021, issued to Jones Ventures INTL Acquisition1 Sponsor LLC**

10.3 Amended Promissory Note, dated March 10, 2021, issued to Jones Ventures INTL Acquisition1 Sponsor LLC**

10.4 Form of Letter Agreement among the Registrant and our officers, directors and Jones Ventures INTL Acquisition1 Sponsor LLC**

10.5 Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company, LLC and the Registrant**

10.6 Form of Registration Rights Agreement between the Registrant and certain shareholders**

10.7 Form of Private Placement Units Purchase Agreement between the Registrant and Jones Ventures INTL Acquisition1 Sponsor LLC**

10.8 Form of Private Placement Rights Purchase Agreement between Registrant and Jones Trading Institutional Services LLC**

Table of Contents

Exhibit Description

10.9 Form of Indemnity Agreement**

10.10 Form of Administrative Services Agreement between the Registrant and [___]**

14 Form of Code of Ethics**

23.1 Consent of CBIZ CPAs P.C.**

23.2 Consent of Maples and Calder (Cayman) LLP (included in Exhibit 5.1)**

24 Power of Attorney (included on the signature page of the initial filing of this Registration Statement)**

99.1 Form of Audit Committee Charter**

99.2 Form of Compensation Committee Charter**

99.3 Consent of [__]**

99.4 Consent of [___]**

107 Filing Fee Table**

*        Filed herewith.

**      To be filed

(b)    Financial Statements.    See page F-1 for an index to the financial statements and schedules included in the registration statement.

Item 17. Undertakings.

(a)     The undersigned registrant hereby undertakes to provide to the underwriters at the closing specified in the underwriting agreements, certificates in such denominations and registered in such names as required by the underwriters to permit prompt delivery to each purchaser.

(b)    Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.

(c)     The undersigned registrant hereby undertakes that:

(1)    For purposes of determining any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective.

(2)    For the purpose of determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

(3)    For the purpose of determining liability under the Securities Act of 1933 to any purchaser, if the registrant is subject to Rule 430C, each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement

Table of Contents

or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.

(4)    For the purpose of determining liability of a registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of an undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:

(i)     Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;